Back to mobile site

Exact Sciences Corp (EXAS) Posts Q2 Loss of 13c/Sh., Wider than Views

August 2, 2011 7:35 AM EDT
Exact Sciences Corp (NASDAQ: EXAS) reported Q2 loss of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.02 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings